Bruker Corporation (BRKR) Key Metrics
BRKR valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $8.35B
- Enterprise value
- $10.69B
- P/E (TTM)
- — 10-yr median 40.5
- Forward P/E
- 13.8
- PEG ratio
- 1.52
- Price / sales
- 2.4 10-yr median 3.4
- Price / book
- 3.8 10-yr median 7.6
- EV / EBITDA
- 39.7 10-yr median 21.4
- Dividend yield
- 0.36% $0.20 a year
- Beta
- 1.22
BRKR key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsBRKR valuation Price multiples at each fiscal year-end price.
Price / sales−20.1%
2.1
2025 · hover or tap a bar for each year
20162025
Price / book−40.8%
2.9
2025 · hover or tap a bar for each year
20162025
EV / EBITDA+19.1%
29.4
2025 · hover or tap a bar for each year
20162025
Price / free cash flow+698.4%
514.5
2025 · hover or tap a bar for each year
20162025
Free cash flow yield−1.4 pts
0.2%
2025 · hover or tap a bar for each year
20162025
BRKR returns How much profit the business earns on the capital it uses.
Return on equity−7.6 pts
−0.4%
2025 · hover or tap a bar for each year
20162025
Return on invested capital−1.7 pts
2.9%
2025 · hover or tap a bar for each year
20162025
Return on assets−2.4 pts
−0.1%
2025 · hover or tap a bar for each year
20162025
Free cash flow margin−3.6 pts
0.4%
2025 · hover or tap a bar for each year
20162025
Asset turnover−14.8%
0.57
2025 · hover or tap a bar for each year
20162025
BRKR per-share figures Results divided by the shares outstanding at year-end.
Revenue per share+0.5%
$22.64
2025 · hover or tap a bar for each year
20162025
Earnings per share
−$0.06
2025 · hover or tap a bar for each year
20162025
Free cash flow per share−89.9%
$0.09
2025 · hover or tap a bar for each year
20162025
Book value per share+35.8%
$16.18
2025 · hover or tap a bar for each year
20162025
Dividends per share−25.6%
$0.15
2025 · hover or tap a bar for each year
20162025
Shares outstanding+1.5%
151.8M
2025 · hover or tap a bar for each year
20162025
BRKR financial health Debt, liquidity and how easily interest is covered.
Debt / equity−34.0%
0.83
2025 · hover or tap a bar for each year
20162025
Net debt−$317.8M
$1.74B
2025 · hover or tap a bar for each year
20162025
Net debt / EBITDA+1.06
5.76
2025 · hover or tap a bar for each year
20162025
Current ratio+7.9%
1.73
2025 · hover or tap a bar for each year
20162025
Interest coverage−25.9%
3.9
2025 · hover or tap a bar for each year
20162025
Debt / assets−15.4%
0.33
2025 · hover or tap a bar for each year
20162025
BRKR efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+5 days
76 days
2025 · hover or tap a bar for each year
20162025
Days of inventory−4 days
212 days
2025 · hover or tap a bar for each year
20162025
Days payables outstanding−2 days
44 days
2025 · hover or tap a bar for each year
20162025
Cash conversion cycle+3 days
244 days
2025 · hover or tap a bar for each year
20162025
Capex / revenue+0.1 pts
3.5%
2025 · hover or tap a bar for each year
20162025
Dividends + buybacks / FCF+213.8 pts
236.0%
2025 · hover or tap a bar for each year
20162025
BRKR valuation history
Fiscal year-endToday10-year median
BRKR returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BRKR debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BRKR cash returned to shareholders
DividendsBuybacksFree cash flow
BRKR price vs earnings per share
Share price at year-endEPS (right axis)
BRKR key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $7.15B | $8.76B | $10.82B | $10.21B | $12.83B | $8.37B | $7.98B | $4.68B | $5.46B | $3.44B |
| Enterprise value | $8.90B | $10.83B | $11.71B | $10.84B | $13.06B | $8.55B | $8.18B | $4.70B | $5.44B | $3.35B |
| P/E ratio | — | 77.5 | 25.3 | 34.4 | 46.3 | 53.0 | 40.5 | 26.0 | 69.5 | 22.4 |
| Price / sales | 2.1 | 2.6 | 3.6 | 4.0 | 5.3 | 4.2 | 3.9 | 2.5 | 3.1 | 2.1 |
| Price / book | 2.9 | 4.9 | 7.9 | 9.2 | 12.0 | 8.7 | 8.8 | 5.2 | 7.4 | 5.0 |
| Price / free cash flow | 514.5 | 64.4 | 44.5 | 71.4 | 67.4 | 35.6 | 56.9 | 24.6 | 49.3 | 36.7 |
| Price / operating cash flow | 53.3 | 34.9 | 30.9 | 39.0 | 45.4 | 25.1 | 37.4 | 19.5 | 35.4 | 26.3 |
| EV / sales | 2.6 | 3.2 | 3.9 | 4.3 | 5.4 | 4.3 | 3.9 | 2.5 | 3.1 | 2.1 |
| EV / EBITDA | 29.4 | 24.7 | 17.3 | 20.9 | 26.3 | 26.7 | 22.0 | 13.8 | 18.2 | 12.8 |
| EV / free cash flow | 640.0 | 79.6 | 48.1 | 75.8 | 68.6 | 36.4 | 58.2 | 24.7 | 49.1 | 35.7 |
| Earnings yield | −0.1% | 1.3% | 3.9% | 2.9% | 2.2% | 1.9% | 2.5% | 3.8% | 1.4% | 4.5% |
| Free cash flow yield | 0.2% | 1.6% | 2.2% | 1.4% | 1.5% | 2.8% | 1.8% | 4.1% | 2.0% | 2.7% |
| Dividend yield | 0.3% | 0.3% | 0.3% | 0.3% | 0.2% | 0.3% | 0.3% | 0.5% | 0.5% | 0.8% |
| Shareholder yield (dividends + buybacks) | 0.5% | 0.3% | 1.7% | 2.9% | 1.4% | 1.8% | 2.1% | 3.8% | 3.3% | 5.4% |
| Share price at fiscal year-end | $47.11 | $58.62 | $73.48 | $68.35 | $83.91 | $54.13 | $50.97 | $29.77 | $34.32 | $21.18 |
| Per share | ||||||||||
| Revenue per share | $22.64 | $22.52 | $20.14 | $16.94 | $15.81 | $12.86 | $13.23 | $12.06 | $11.10 | $9.93 |
| Earnings per share | −$0.06 | $0.76 | $2.90 | $1.99 | $1.81 | $1.02 | $1.26 | $1.14 | $0.49 | $0.95 |
| Operating cash flow per share | $0.88 | $1.68 | $2.38 | $1.75 | $1.85 | $2.16 | $1.36 | $1.52 | $0.97 | $0.81 |
| Free cash flow per share | $0.09 | $0.91 | $1.65 | $0.96 | $1.25 | $1.52 | $0.90 | $1.21 | $0.70 | $0.58 |
| Cash per share | $1.97 | $1.23 | $3.32 | $4.32 | $7.64 | $4.73 | $4.37 | $2.05 | $2.76 | $3.08 |
| Book value per share | $16.18 | $11.91 | $9.36 | $7.46 | $7.00 | $6.22 | $5.79 | $5.76 | $4.61 | $4.27 |
| Tangible book value per share | $0.06 | −$4.27 | $3.15 | $2.58 | $3.40 | $2.66 | $2.43 | $2.61 | $1.51 | $3.04 |
| Dividends per share | $0.15 | $0.20 | $0.20 | $0.20 | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 |
| Capex per share | $0.79 | $0.77 | $0.73 | $0.80 | $0.60 | $0.64 | $0.47 | $0.31 | $0.27 | $0.23 |
| Debt per share | $13.46 | $15.02 | $9.37 | $8.50 | $9.12 | $5.90 | $5.63 | $2.17 | $2.61 | $2.54 |
| Shares outstanding | 151.8M | 149.5M | 147.2M | 149.4M | 152.9M | 154.6M | 156.6M | 157.2M | 159.1M | 162.2M |
| Change in shares outstanding | +1.5% | +1.6% | −1.5% | −2.3% | −1.1% | −1.3% | −0.4% | −1.2% | −1.9% | −4.1% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −0.4% | 7.2% | 34.3% | 27.2% | 27.3% | 16.9% | 21.8% | 21.9% | 11.0% | 21.5% |
| Return on invested capital (ROIC) | 2.9% | 4.6% | 17.1% | 20.5% | 24.2% | 15.8% | 21.0% | 23.8% | 16.3% | 27.1% |
| Return on assets (ROA) | −0.1% | 2.2% | 10.9% | 8.2% | 8.3% | 5.4% | 8.0% | 8.8% | 4.2% | 8.7% |
| Return on tangible assets | −0.2% | 3.3% | 12.8% | 10.3% | 8.9% | 6.3% | 8.8% | 11.0% | 5.4% | 9.5% |
| Free cash flow margin | 0.4% | 4.0% | 8.2% | 5.7% | 7.9% | 11.8% | 6.8% | 10.0% | 6.3% | 5.8% |
| Income quality (OCF / net income) | — | 2.22 | 0.82 | 0.88 | 1.02 | 2.11 | 1.08 | 1.33 | 1.96 | 0.85 |
| Financial health | ||||||||||
| Total debt | $2.04B | $2.25B | $1.38B | $1.27B | $1.39B | $912.8M | $880.9M | $341.1M | $415.6M | $411.7M |
| Cash & short-term investments | $298.8M | $183.4M | $488.3M | $645.5M | $1.17B | $731.8M | $684.9M | $322.4M | $439.2M | $500.3M |
| Net debt | $1.74B | $2.06B | $891.3M | $624.9M | $225.7M | $181.0M | $196.0M | $18.7M | −$23.6M | −$88.6M |
| Debt / equity | 0.83 | 1.26 | 1.00 | 1.14 | 1.30 | 0.95 | 0.97 | 0.38 | 0.57 | 0.59 |
| Debt / assets | 0.33 | 0.39 | 0.32 | 0.35 | 0.38 | 0.30 | 0.32 | 0.16 | 0.21 | 0.23 |
| Net debt / EBITDA | 5.76 | 4.70 | 1.32 | 1.20 | 0.45 | 0.56 | 0.53 | 0.05 | −0.08 | −0.34 |
| Current ratio | 1.73 | 1.60 | 1.80 | 2.31 | 2.63 | 2.43 | 2.78 | 2.18 | 2.59 | 2.42 |
| Quick ratio | 0.87 | 0.77 | 0.99 | 1.44 | 1.88 | 1.56 | 1.89 | 1.33 | 1.66 | 1.58 |
| Interest coverage | 3.9 | 5.3 | 26.6 | 26.9 | 28.9 | 17.2 | 18.8 | 20.8 | 13.9 | 13.4 |
| Working capital | $933.3M | $771.9M | $962.1M | $1.20B | $1.53B | $1.13B | $1.15B | $706.3M | $834.3M | $746.9M |
| Invested capital | $4.20B | $3.84B | $2.27B | $1.74B | $1.30B | $1.14B | $1.10B | $923.8M | $709.9M | $604.5M |
| Tangible asset value | $63.0M | −$604.6M | $500.2M | $403.3M | $533.5M | $424.8M | $412.0M | $410.7M | $240.5M | $492.8M |
| Net current asset value | −$1.52B | −$1.94B | −$672.4M | −$366.8M | −$93.4M | −$149.7M | −$37.0M | $80.8M | $143.8M | $153.0M |
| Graham number | — | $14.24 | $24.72 | $18.25 | $16.90 | $11.95 | $12.81 | $12.17 | $7.16 | $9.54 |
| Graham net-net per share | −$15.37 | −$18.38 | −$9.50 | −$6.61 | −$4.77 | −$4.82 | −$3.76 | −$2.41 | −$1.84 | −$1.33 |
| Capital allocation | ||||||||||
| Dividends paid | $22.8M | $30.2M | $29.4M | $29.8M | $24.2M | $24.6M | $25.0M | $25.1M | $25.4M | $25.8M |
| Share buybacks (net) | $10.0M | $0 | $152.3M | $263.1M | $153.3M | $123.2M | $142.3M | $152.2M | $152.2M | $160.0M |
| Dividend payout ratio | — | 26.7% | 6.9% | 10.0% | 8.7% | 15.6% | 12.7% | 14.0% | 32.3% | 16.8% |
| Dividends + buybacks / free cash flow | 236.0% | 22.2% | 74.7% | 204.8% | 93.2% | 62.9% | 119.2% | 93.1% | 160.4% | 198.3% |
| Capex / revenue | 3.5% | 3.4% | 3.6% | 4.7% | 3.8% | 4.9% | 3.5% | 2.6% | 2.5% | 2.3% |
| Capex / operating cash flow | 89.6% | 45.9% | 30.5% | 45.4% | 32.6% | 29.5% | 34.2% | 20.5% | 28.3% | 28.4% |
| Capex / depreciation | 0.55 | 0.63 | 0.93 | 1.35 | 1.03 | 1.22 | 0.97 | 0.76 | 0.68 | 0.68 |
| Stock-based compensation / revenue | 0.6% | 0.8% | 0.8% | 1.1% | 0.7% | 0.8% | 0.5% | 0.6% | 0.6% | 0.6% |
| R&D / revenue | 11.5% | 11.2% | 9.9% | 9.3% | 9.1% | 10.0% | 9.1% | 9.1% | 9.2% | 9.2% |
| SG&A / revenue | 27.5% | 26.6% | 24.6% | 24.2% | 23.4% | 24.5% | 24.4% | 23.5% | 23.6% | 24.2% |
| Efficiency | ||||||||||
| Days sales outstanding | 76.3 | 71.7 | 74.9 | 73.0 | 56.8 | 64.0 | 63.3 | 65.1 | 58.2 | 54.2 |
| Days of inventory on hand | 212.3 | 216.4 | 222.4 | 225.0 | 211.8 | 221.1 | 184.1 | 182.5 | 177.5 | 181.2 |
| Days payables outstanding | 44.2 | 46.4 | 47.9 | 48.5 | 42.6 | 44.1 | 37.8 | 35.8 | 33.9 | 33.2 |
| Cash conversion cycle (days) | 244.5 | 241.7 | 249.4 | 249.4 | 226.0 | 241.1 | 209.7 | 211.9 | 201.8 | 202.1 |
| Receivables turnover | 4.78 | 5.09 | 4.87 | 5.00 | 6.43 | 5.70 | 5.76 | 5.60 | 6.27 | 6.73 |
| Payables turnover | 8.26 | 7.86 | 7.62 | 7.52 | 8.57 | 8.28 | 9.67 | 10.20 | 10.77 | 10.98 |
| Inventory turnover | 1.72 | 1.69 | 1.64 | 1.62 | 1.72 | 1.65 | 1.98 | 2.00 | 2.06 | 2.01 |
| Asset turnover | 0.57 | 0.67 | 0.75 | 0.70 | 0.72 | 0.68 | 0.85 | 0.93 | 0.94 | 0.91 |
| Average receivables | $718.6M | $661.5M | $608.5M | $506.1M | $376.1M | $348.8M | $359.7M | $338.2M | $281.6M | $239.3M |
| Average payables | $225.0M | $218.4M | $190.6M | $162.9M | $141.0M | $126.5M | $111.5M | $97.7M | $88.5M | $79.1M |
| Average inventory | $1.08B | $1.02B | $884.2M | $755.1M | $701.2M | $634.8M | $543.4M | $497.9M | $463.3M | $431.2M |
| Intangibles / total assets | 39.2% | 41.7% | 21.5% | 20.2% | 15.1% | 18.0% | 19.0% | 23.2% | 25.3% | 11.0% |
Computed from BRKR's annual financial statements (latest annual report filed February 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BRKR valuation and financial ratios
Bruker earned a return on equity of −0.4% and a return on invested capital of 2.9% in fiscal 2025. It ended the year with $2.0 billion of debt and $298.8 million in cash and short-term investments, net debt of $1.7 billion. It returned $32.8 million to shareholders: $22.8 million in dividends and $10.0 million in share buybacks, 236% of free cash flow. The share count fell 6.4% from 162.2M to 151.8M over 9 years.
See the BRKR income statement, the BRKR chart for price history, or the BRKR stock overview for the latest quote and news.
BRKR key metrics FAQ
What is Bruker's EV/EBITDA?
Bruker's enterprise value was 29.4 times EBITDA at the end of fiscal 2025 (enterprise value $8.9 billion, EBITDA $302.6 million); the current EV/EBITDA is 39.7.
What is Bruker's return on equity?
Bruker's return on equity (ROE) was −0.4% in fiscal 2025: net income of -$8.6 million on average shareholders' equity of $2.1 billion.
What is Bruker's ROIC?
Bruker's return on invested capital was 2.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Bruker have?
Bruker had total debt of $2.0 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.83 and $1.7 billion of net debt (5.76 times EBITDA).
What is Bruker's dividend yield?
Bruker's forward dividend yield is 0.36%. Bruker paid $22.8 million in dividends in fiscal 2025 ($0.15 per share), a payout ratio of —.
Does Bruker buy back its shares?
Yes. Bruker spent $10.0 million on net share repurchases in fiscal 2025 Shares outstanding changed +1.5% over the year, to 151.8M..
What is Bruker's free cash flow yield?
Bruker generated $13.9 million of free cash flow in fiscal 2025, a free cash flow yield of 0.2% on its market value at year-end ($7.2 billion).
What is Bruker's current ratio?
Bruker's current ratio was 1.73 at the end of fiscal 2025: current assets were 1.73 times current liabilities.